In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Ortho terminates BMP-7 program with Curis

Executive Summary

Curis (tissue regeneration) has licensed development and marketing rights pertaining to its bone morphogenetic protein (BMP) technology portfolio and preclinical compounds to Johnson & Johnson's Ortho Biotech unit initially for the development of treatments for kidney disease complications vascular calcification and renal osteodystrophy.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Contract
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register